➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Harvard Business School
McKesson
Mallinckrodt
Merck

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Aurobindo Pharma FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 079245 ANDA Rising Health, LLC 57237-026-01 100 TABLET in 1 BOTTLE (57237-026-01)
Aurobindo Pharma FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 079245 ANDA Rising Health, LLC 57237-026-30 30 TABLET in 1 BOTTLE (57237-026-30)
Aurobindo Pharma FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 079245 ANDA Rising Health, LLC 57237-027-01 100 TABLET in 1 BOTTLE (57237-027-01)
Aurobindo Pharma FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 079245 ANDA Rising Health, LLC 57237-027-30 30 TABLET in 1 BOTTLE (57237-027-30)
Aurobindo Pharma FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 079245 ANDA Aurobindo Pharma Limited 65862-308-01 100 TABLET in 1 BOTTLE (65862-308-01)
Aurobindo Pharma FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 079245 ANDA Aurobindo Pharma Limited 65862-308-30 30 TABLET in 1 BOTTLE (65862-308-30)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
AstraZeneca
Baxter
Dow
Merck